Ablative fractional CO<sub>2</sub> laser for burn scar reconstruction: An extensive subjective and objective short-term outcome analysis of a prospective treatment cohort.
prospective_cohort · Level II
Where this comes from
- Record sourced from PubMed, PMID 27707636.
- Also identified by DOI 10.1016/j.burns.2016.09.014.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
The introduction of ablative fractional CO<sub>2</sub> lasers (CO<sub>2</sub>-AFL) for burn scar management shows promising results. Whilst recent studies have focused on objective scar outcomes following CO<sub>2</sub>-AFL treatment, to date no data on patient subjective factors such as quality of life are available. A prospective study was initiated to analyze the safety and efficacy of the CO<sub>2</sub>-AFL. Various objective and subjective outcome parameters were prospectively collected from the date of first consultation and follow-up following treatment. Objective factors include the Vancouver Scar Scale (VSS), the Patient and Observer Scar Assessment Scale (POSAS), and ultrasound measurements of the thickness of the scar. Subjective parameters included the assessment of neuropathic pain and pruritus, as well as the evaluation of improvement of quality of life following CO<sub>2</sub>-AFL with the Burns Specific Health Scale (BSHS-B). For treatment effect analysis, patients were stratified according to scar maturation status (> or <2 years after injury). 47 patients with 118 burn scars completed at least one treatment cycle. At a median of 55 days (IQR 32-74) after CO<sub>2</sub>-AFL treatment all analyzed objective parameters decreased significantly: intra-patient normalized scar thickness decreased from a median of 2.4mm to 1.9mm (p<0.001) with a concomitant VSS-drop from a median of 7 to 6 (p<0.001). The overall POSAS patient scale decreased from a median of 9 to 5 (p<0.001) with similar effects documented in POSAS observer scales. Both pain and pruritus showed significant reduction. Quality of life increased significantly by 15 points (median 120 to 135; p<0.001). All of the identified changes following CO<sub>2</sub>-AFL were equally significant irrespective of scar maturation status. Our preliminary results confirm significant improvement in thickness, texture, colour, and symptoms following treatment with CO<sub>2</sub>-AFL. Foremost, quality of life of patients with both immature and mature scars (up to 23 years after injury) improved significantly after just one treatment session. To our knowledge, this is the first study to document such holistic treatment effects in burn patients treated by CO<sub>2</sub>-AFL.
Medical subject headings
- Burns
- Cicatrix
- Laser Therapy
- Lasers, Gas